Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis.


Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
11 2020
Historique:
received: 13 08 2019
accepted: 13 06 2020
pubmed: 7 7 2020
medline: 23 7 2021
entrez: 7 7 2020
Statut: ppublish

Résumé

Enhanced Recovery After Surgery (ERAS) is a perioperative approach to managing surgical patients. The impact of ERAS on radical cystectomy (RC) outcomes remains understudied. To review the literature regarding ERAS protocols and RC outcomes. The primary outcome was hospital length of stay (LOS). A systematic review of the articles published from 1970 through 2018 was conducted. Individual patient data (IPD) were requested and a meta-analysis was performed. A total of 4197 articles were retrieved and 22 (reporting 4048 patients) were selected for the review. LOS followed by 30-d and that followed by 90-d complications were the most common endpoints. ERAS use was associated with reduced morbidity, quicker bowel recovery, and shorter LOS, without affecting mortality. IPD were obtained for 2077 patients from 11 studies. In multivariable models, LOS was associated with ERAS use (regression coefficient: -4.54 [95% confidence interval {CI}: -5.79 to -3.28] d with ERAS p <  0.001) and Charlson Comorbidity Index (+1.64 [1.38-1.90] d for each point increase, p <  0.001), and varied between hospitals (from -1.59 [-3.03 to -0.14] to +4.55 [1.89-7.21] d, p <  0.03). Individual ERAS components associated with shorter LOS included no nasogastric (NG) tube (-8.70 [-11.9 to -5.53] d, p <  0.001) and local anesthesia blocks compared with regional anesthesia (-3.29 [-6.31 to -0.27] d, p =  0.03). ERAS protocols were associated with reduced LOS and postoperative complication rate. Avoidance of NG tubes and use of local anesthesia blocks were significantly associated with reduced LOS. These findings reflect different components of recovery, which ERAS can optimize and further support documentation of the use of ERAS components when reporting RC outcomes. Use of enhanced recovery in patients undergoing surgery to remove the bladder is associated with fewer surgical complications and a shorter hospital stay. Avoidance of nasogastric tubes and use of local anesthesia after the operation were associated with a shorter length of stay.

Identifiants

pubmed: 32624275
pii: S0302-2838(20)30468-1
doi: 10.1016/j.eururo.2020.06.039
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

719-730

Subventions

Organisme : Department of Health
ID : NIHR300047
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 European Association of Urology. All rights reserved.

Auteurs

Stephen B Williams (SB)

Division of Urology, The University of Texas Medical Branch, Galveston, TX, USA.

Marcus G K Cumberbatch (MGK)

Academic Urology Unit, University of Sheffield, Sheffield, UK.

Ashish M Kamat (AM)

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ibrahim Jubber (I)

Academic Urology Unit, University of Sheffield, Sheffield, UK.

Preston S Kerr (PS)

Division of Urology, The University of Texas Medical Branch, Galveston, TX, USA.

John S McGrath (JS)

Department of Urology, Royal Devon and Exeter NHS Trust, Exeter, UK.

Hooman Djaladat (H)

USC Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.

Justin W Collins (JW)

Department of Urology, University College London Hospital, London, UK.

Vignesh T Packiam (VT)

Department of Urology, Mayo Clinic, Rochester, MN, USA.

Gary D Steinberg (GD)

Department of Urology, New York University, New York, NY, USA.

Eugene Lee (E)

Department of Urology, University of Kansas, Kansas City, KS, USA.

Wassim Kassouf (W)

Department of Urology, McGill University Health Center, Montreal, QC, Canada.

Peter C Black (PC)

Department of Urologic Science, University of British Columbia, Vancouver, BC, Canada.

Yannick Cerantola (Y)

Service d'urologie, CHU vaudois, Lausanne, Switzerland.

James W F Catto (JWF)

Academic Urology Unit, University of Sheffield, Sheffield, UK. Electronic address: j.catto@sheffield.ac.uk.

Siamak Daneshmand (S)

USC Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. Electronic address: daneshma@med.usc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH